Precision Medicine acquires Project Farma

By The Science Advisory Board staff writers

January 15, 2021 -- Precision Medicine has acquired Project Farma, a bioengineering services firm.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion. The company has been involved in the development of several cell and gene therapy medicines.

The firm will be part of Precision for Medicine, Precision Medicine's research and development services arm.

Copyright © 2021

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter